|Articles|November 3, 2022
Precision for Medicine Announces Culmination of Next Generation Sequencing Initiative
Next Generation Sequencing (NGS) initiative improved the accuracy and speed of identifying cancer mutations in solid tumors.
Advertisement
Precision for Medicine announced the culmination of its Next Generation Sequencing (NGS) initiative which improved the accuracy and speed of identifying cancer mutations in solid tumors, allowing researchers and manufacturers to develop patient-specific diagnostics for improved clinical outcomes.
Read more about the initative
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Medidata, BioRender Announce New AI Partnerships Expanding Capabilities in Life Sciences
2
ACT Brief: Digital Consent, Global Diversity, and Clinical Setbacks Shape Today’s Clinical Research Landscape
3
Bringing Clinical Trials Into the Digital Era with eConsent
4
Rethinking Trial Access in Lower-Income Regions Through Patient-Centric, AI-Driven Models
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
